Mcf Advisors LLC Axonics, Inc. Transaction History

Mcf Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$49.38 - $63.75 $3,752 - $4,845	-76 Reduced 11.95%	560 $34,000
Q3 2023 Oct 19, 2023	BUY	$48.64 - $62.51 $2,480 - $3,188	51 Added 8.72%	636 $35,000
Q2 2023 Jul 24, 2023	BUY	$47.99 - $60.21 $5,806 - $7,285	121 Added 26.08%	585 $29,000
Q1 2023 Apr 18, 2023	BUY	$52.6 - $67.34 $1,683 - $2,154	32 Added 7.41%	464 $25,000
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $25,038 - $33,747	432 New	432 $30,000

217

41.6M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.